Francesco Bellanti | Epatologia | Research Excellence Award

Published on by Invention Awards

Assoc. Prof. Dr. Francesco Bellanti | Epatologia | Research Excellence Award

Department of Medical and Surgical Sciences, University of Foggia, Italy

Assoc. Prof. Dr. Francesco Bellanti is an Italian physician–scientist at the University of Foggia with a Medical Degree, Specialty in Internal Medicine, and a PhD in Clinical, Medical and Experimental Sciences, complemented by international training through Erasmus, postdoctoral, and visiting fellowships in Spain, France, and the UK. His research focuses on liver disease, aging, redox biology, mitochondrial dysfunction, and metabolic disorders, supported by multiple competitive grants and prestigious awards from national and European scientific societies. He has served as principal or co-investigator in several national and multicentre clinical registries and trials, including studies on diabetes, COVID-19, primary biliary cholangitis, and polypharmacy. Dr. Bellanti has extensive teaching experience across medicine, emergency medicine, and internal medicine for multiple health disciplines, with regular visiting professorships across Europe. He has been actively involved in postgraduate supervision, mentoring PhD students, medical residents, and undergraduate students in medicine, nutrition, and allied health sciences. His academic career reflects a strong integration of clinical practice, translational research, international collaboration, and long-term commitment to medical education.

Citation Metrics (Scopus)

5000
4000
3000
2000
1000
0

Citations
4122

Documents
110

h-index
35

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Dawit Dibekulu | Psychology | Editorial Board Member

Published on by Invention Awards

Dr. Dawit Dibekulu | Psychology | Editorial Board Member

Assistant Professor in Bahir Dar University, Ethiopia

Dr. Dawit Dibekulu Alem is an Assistant Professor at Mekdela Amba University, College of Social Sciences and Humanities, Department of English Language and Literature. He earned his BA in English Language and Literature from Woldia University, MA in TEFL from Debre Markos University, and Ph.D. in Literature from Bahir Dar University. His research encompasses language assessment, literature, comparative literature, psychoanalysis, cultural studies, language-learning strategies, CALL, material development, psychology, educational psychology, and curriculum design. Dr. Dawit has published numerous research articles in both national and international journals, presented papers at global conferences, and serves as an Editorial Board Member of PLOS ONE and Review Board Member for multiple international journals, including the International Journal of Psychology and Counselling, International Journal of Learning, Teaching, and Educational Research, African Educational Research Journal, and International Journal of English and Literature. He has participated in major conferences such as GLOBETS 2023, GlobELT 2021, and the 4th African Graduate Students Conference, presenting on themes of mourning, pedagogy, and stylistics in Amharic novels. His career spans teaching, research, and leadership roles, including University-Industry Linkage Director and Research Coordinator at Mekdela Amba University. Dr. Dawit’s scholarly work reflects a deep commitment to advancing interdisciplinary understanding in language, culture, and education. He has published over 20 papers, holds an h-index of 4, and has received more than 120 citations. His achievements have been recognized through multiple honors, including the Best Lecturer of the Year Award from the Ethiopian Ministry of Education and the Best Worker of the Year Award from the Ministry of Culture and Tourism.

Profiles: Scopus | Orcid | Google Scholar 

Featured Publications

Guadu, A., Dibekulu, D., & Menberu, A. W. (2025). Artificial intelligence in African higher education: Uses, misuses, and ethical dilemmas. Advances in Artificial Intelligence and Machine Learning, 5(3), 234.

Weldesenbet, S. A., Dibekulu, D., & Addis, A. (2025). Adolescents’ social media usage and their premarital sexual attitude in Bole Sub City, Addis Ababa, Ethiopia: A quantitative exploration. Sexuality & Culture. Advance online publication.

Dibekulu, D., Surineni, K., Dagnew, T., & G/Meskel, T. (2025). Exploring ambivalence: A psychoanalytic analysis of emotional complexity in selected Amharic novels. PLOS ONE, 20(7), e0327631.

Guadu, A., & Dibekulu, D. (2025). Female beauty as a symbol of the nation in selected Ethiopian novels in English: An intertextual study. Forum for Linguistic Studies, 7(5), 9388.

Dibekulu, D., Dagnew, T., & G. Meskel, T. (2024). Mourning in selected contemporary Amharic novel: A meta-psychological perspective. European Journal of Trauma and Dissociation, 8(1), 100402.

Dibekulu, D. (2024). Teddy Afro’s music: A fusion of nationalism, humanism, and the cry for Ethiopian democracy. European Journal of Arts, Humanities and Social Sciences, 1(3), 1–10.

Dibekulu, D., Dagnew, T., & G. Meskel, T. (2023). Melancholy in selected contemporary Amharic novel The novel Yaqnat Zar (“Zar of Jealousy”). Journal of Language and Cultural Education, 11(3), 1–10.

Amedeo Lonardo | Epatologia | Lifetime achievement Award

Published on by Invention Awards

Dr. Amedeo Lonardo | Epatologia | Lifetime Achievement Award 

Azienda Ospedaliero-Univresitaria di Modena | Italy

Dr. Amedeo Lonardo is a distinguished medical scientist and clinician, holding specializations in Gastroenterology, Pediatrics, and Internal Medicine. He is qualified as Full Professor of Gastroenterology and Associate Professor of Internal Medicine by the Italian National Examination (2017). With a prolific academic career, he has authored 279 scientific publications that have collectively received 19,170 citations as of October 2025, reflecting his enduring influence in hepatology and metabolic research. His h-index stands at 69 (Scopus) and 78 (Google Scholar and ScholarGPS), highlighting his international research impact. Dr. Lonardo currently serves as Founding Editor and Editor-in-Chief of Metabolism and Target Organ Damage (since 2021) and Editor-in-Chief of Metabolites (since 2024), and also contributes as Associate Editor for Exploration of Medicine and as a member of the editorial boards of Liver International, Digestive and Liver Disease, Advances in Therapy, Exploration of Digestive Diseases, and Exploration of Drug Science. With over 546 editorial records and 1,342 peer review contributions documented in Web of Science, he stands among the most active academic editors in his field. His work has involved collaboration with 2,572 international co-authors, underscoring his extensive global scientific network. Dr. Lonardo’s research focuses primarily on sex differences and metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as NAFLD. He pioneered investigations into the influence of sex and sex hormones on fatty liver disease pathogenesis (PMIDs: 10937684, 16618516, 19347015), and expanded this domain to include endocrinological and extrahepatic implications (PMIDs: 31212642, 30084737, 30733187, 39794250, 40566760). His most influential and highly cited reviews published in The Lancet (PMID: 32828189) and Hepatology (PMID: 30924946) have shaped the modern understanding of gender-related differences in MASLD, consolidating his reputation as a global leader in hepatology and metabolic research.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Weiskirchen, R., & Lonardo, A. (2025). Sex hormones and metabolic dysfunction-associated steatotic liver disease. International Journal of Molecular Sciences, 26(19), 9594.

Jamalinia, M., Zare, F., Mantovani, A., Targher, G., & Lonardo, A. (2025). Metabolic dysfunction-associated steatotic liver disease and sex-specific risk of fatal and non-fatal cardiovascular events: A meta-analysis. Diabetes, Obesity and Metabolism, 27(9), e16568.

Lonardo, A., & Weiskirchen, R. (2025). Tirzepatide in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: A novel star on the horizon? Exploration of Drug Science, 3, 1008128.

Lonardo, A., Zheng, M.-H., & Weiskirchen, R. (2025). Food insecurity is an emerging risk factor for liver disease: A scoping review. Expert Review of Gastroenterology & Hepatology, 19(9), 2545812.

Lonardo, A., & Weiskirchen, R. (2025). PPARs in molecular pathogenesis and drug treatment of type 2 diabetes-related MASLD. Exploration of Digestive Diseases, 3, 100590.

Lonardo, A., Zheng, M.-H., & Eslam, M. (2025). MASLD vs. MAFLD: A narrative review. Exploration of Digestive Diseases, 3, 100586.

Lonardo, A., Stefan, N., & Mantovani, A. (2025). Widening research horizons on metabolic dysfunction-associated steatotic liver disease and cancer. Trends in Endocrinology & Metabolism, 36(7),

Weiskirchen, R., & Lonardo, A. (2025). The ovary–liver axis: Molecular science and epidemiology. International Journal of Molecular Sciences, 26(13), 6382.

Shibel Ageel | Medicine | Best Researcher Award

Published on by Invention Awards

Dr. Shibel Ageel | Medicine | Best Researcher Award 

Dr. Shibel Ageel | Faculty of Medicine Novi Sad | Croatia

Dr. Shibel Ageel is a dedicated and multilingual medical doctor educated at the Medical Faculty of Novi Sad, University of Novi Sad, graduating in June 2024 as one of the top-ranking students. He has gained broad and diverse clinical experience across Croatia, Serbia, and Tunisia, completing rotations in otorhinolaryngology and head and neck surgery, plastic and reconstructive surgery, general and abdominal surgery, and demonstrating strong technical and diagnostic skills consistently praised by senior surgeons. His passion for surgery, research, and teaching is evident through active participation and poster presentations at numerous medical conferences, including the Osijek Student Congress (OSCON 2020–2024), SaMED 2020 in Sarajevo, and IMSCNS 2019 in Novi Sad. Dr. Ageel has authored and co-authored five peer-reviewed publications including studies and case reports in the MDPI Journal and other indexed medical journals, covering topics such as septoplasty outcomes, fetal tuberous sclerosis, gastric trichobezoars, uterine prolapse, and prurigo diabeticorum. His research bridges surgical innovation and clinical case documentation, contributing valuable insights into ENT and surgical case management. Recognized for his excellence, he received multiple awards including Best Poster Presentation at OSCON 2023, Best Conference Ambassador at OSCON 2024, and a City of Osijek Scholarship for academic distinction. Certified in Basic Life Support (2018) and Advanced Life Support (2024) by the European Resuscitation Council, he combines clinical competence with academic rigor and communication skills. His publications have collectively received growing scholarly recognition with 35 citations in indexed databases and an h-index of 2, reflecting his early yet impactful research trajectory. Driven by curiosity, empathy, and intercultural competence, Dr. Ageel continues to advance in the medical field through clinical excellence, patient-centered care, and research that integrates evidence with global medical collaboration.

Profile: Orcid 

Featured Publications

Tomljenovic, D., Grguric, L., Knežević, M., Svetina, L., Geber, G., Vagic, D., Shibel, A., & Kosec, A. (2025). Comparing nasal patency outcomes in patients undergoing septoplasty with radiofrequency turbinate reduction, turbinectomy, or valvuloplasty: A prospective cohort study. Medicina, 61(9), 1656.

Herman Perroud | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Dr. Herman Perroud | Medicine and Dentistry | Best Researcher Award

Medical Oncology of Sanatorio de la mujer, Argentina

Dr. Herman Perroud is a distinguished MEDICAL ONCOLOGIST affiliated with SANATORIO DE LA MUJER, focusing on innovative research in BREAST CANCER and LUNG CANCER. His career is marked by leadership in the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and oversight of numerous clinical trials. With memberships in ASCO and ESMO, he contributes extensively to oncological advancements. Dr. Perroud’s contributions include publications in prominent journals, exploring new strategies like LOW DOSE CHEMOHERAPY for BREAST CANCER treatment. Recognized internationally for his scientific innovations, he continues to shape the field of oncology with dedication and expertise. 🌟🔬

Professional Profile:

 

Education🎓

Dr. Herman Perroud is a dedicated MEDICAL ONCOLOGIST at SANATORIO DE LA MUJER, focusing on BREAST CANCER and LUNG CANCER research. His academic endeavors include spearheading the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and contributing to clinical trials.

 

Professional Experience 📚

 

Dr. Herman Perroud, a distinguished Medical Oncologist affiliated with Sanatorio de la Mujer, brings extensive expertise in oncology and clinical research. With a robust career spanning years of dedicated service, he has contributed significantly to advancing cancer treatment methodologies, particularly in breast and lung cancers. Dr. Perroud leads multiple clinical trials, including an innovative Early Detection Program for Lung Cancer in Rosario, Argentina. His professional journey includes collaborations with international bodies like ASCO and ESMO, underscoring his commitment to global oncological advancements. Dr. Perroud’s impactful research, published in prestigious journals, focuses on early cancer detection and novel chemotherapy approaches for breast cancer treatment.

Research Interest 🔍

Dr. Herman Perroud’s research interests 🧬🔬 revolve around pioneering advancements in oncology, particularly focusing on breast and lung cancers. He is committed to exploring innovative methods for early cancer detection and refining therapeutic approaches, including low-dose chemotherapy. Dr. Perroud’s research aims to deepen the understanding of tumor biology and treatment modalities through rigorous clinical trials and collaborative studies. His work also encompasses investigating personalized medicine strategies and novel therapies to enhance treatment effectiveness and patient care in oncology.

Award and Honor🏆

Dr. Herman Perroud has received prestigious awards and honors in recognition of his contributions to medical oncology and research. His accolades underscore his dedication to advancing treatments for breast and lung cancers through innovative approaches. These awards highlight his significant impact on early detection methods for lung cancer in Rosario, Argentina, and his pioneering work in low-dose chemotherapy for breast cancer treatment. Dr. Perroud’s achievements are a testament to his leadership in the field, enhancing patient care and advancing scientific knowledge in oncology. 🏆🌟

Research Skills🌟

Dr. Herman Perroud is highly skilled in conducting cutting-edge research in the field of medical oncology, particularly focusing on breast cancer and lung cancer. His research skills encompass a wide range of methodologies, including clinical trials management and the implementation of innovative early detection programs. He demonstrates proficiency in data analysis, experimental design, and the application of advanced medical technologies to improve cancer diagnosis and treatment outcomes. Dr. Perroud’s contributions to the field reflect his deep commitment to advancing oncological research and translating scientific findings into impactful clinical practices, thereby significantly benefiting patients and the medical community alike.

Achievements🏅

  • Spearheaded the Early Detection Program of Lung Cancer in Rosario, Argentina.
  • Managed multiple clinical trials focusing on innovative treatments for breast cancer and lung cancer.
  • Published extensively in reputable journals on advancements in early cancer detection and low-dose chemotherapy.
  • Received international recognition and awards for contributions to oncological research.
  • Active member of prestigious organizations such as ASCO (American Society of Clinical Oncology) and ESMO (European Society for Medical Oncology).
  • Established collaborations with prominent researchers and institutions globally.
  • Contributed significantly to the development of new methodologies in cancer research and treatment.
  • Recognized for leadership in integrating research findings into clinical practice to enhance patient care and outcomes.

Publications🏅

  • Book Chapter
    • Title: Protective effect of Vitamin A on male lung cancer
    • Authors: Dagatti, M.S., Compagnucci, A.B., Perroud, H.A., Pezzotto, S.M.
    • Book: Vitamin A: Nutrition, Side Effects and Supplements, 2021, pp. 193–210
  • Review Article
    • Title: Achievements and challenges in the use of metronomics for the treatment of breast cancer
    • Authors: Scharovsky, O.G., Rico, M.J., Mainetti, L.E., Perroud, H.A., Rozados, V.R.
    • Journal: Biochemical Pharmacology, 2020, 175, 113909
  • Article
    • Title: Correlation between predictors of coledocolithasis and findings of endoscopic retrograde cholangiopancreatography. From guidelines to practice | Correlación entre predictores de litiasis coledociana y los hallazgos en la colangiopancreatografía retrógrada endoscópica. De las guías a la práctica
    • Authors: Ripari, G., Wulfson, A., Guerrina, C., Perroud, H.
    • Journal: Acta Gastroenterologica Latinoamericana, 2017, 47(4), pp. 269–276
  • Article
    • Title: Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay
    • Authors: Rico, M.J., Perroud, H.A., Herrera, C., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2017, 35(6), pp. 377–385
  • Article
    • Title: The association between osteoporotic hip fractures and actinic lesions as a biomarker for cumulative sun exposure in older people—a retrospective case–control study in Argentina
    • Authors: Perroud, H.A., Dagatti, M.S., Amigot, B., Masoni, A.M., Pezzotto, S.M.
    • Journal: Journal of Bone and Mineral Metabolism, 2017, 35(3), pp. 324–329
  • Article
    • Title: Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Scharovsky, O.G., Rozados, V.R., Alasino, C.M.
    • Journal: ecancermedicalscience, 2017, 11, 723
  • Article
    • Title: A nested case-control study on dietary fat consumption and the risk for gallstone disease
    • Authors: Bertola Compagnucci, A., Perroud, H.A., Batallés, S.M., Berli, D., Pezzotto, S.M.
    • Journal: Journal of Human Nutrition and Dietetics, 2016, 29(3), pp. 338–344
  • Article
    • Title: Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Future Oncology, 2016, 12(10), pp. 1233–1242
  • Article
    • Title: Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: Clinical outcomes and biomarkers of response
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Chemotherapy and Pharmacology, 2016, 77(2), pp. 365–374
  • Article
    • Title: Comparative effectiveness of two metronomic chemotherapy schedules-our experience in the preclinical field
    • Authors: Rico, M.J., Perroud, H.A., Mainetti, L.E., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2014, 32(3), pp. 92–98